BlackRock Investment Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$11.2M Buy
279,106
+44,544
+19% +$1.68M 0.01% 1046
2016
Q3
$8.49M Buy
234,562
+2,293
+1% +$78.7K 0.01% 1109
2016
Q2
$6.73M Buy
232,269
+21,679
+10% +$655K 0.01% 1219
2016
Q1
$7.37M Buy
210,590
+4,503
+2% +$145K 0.01% 1116
2015
Q4
$6.64M Buy
206,087
+419
+0.2% +$13.6K 0.01% 1195
2015
Q3
$6.65M Sell
205,668
-1,663
-0.8% -$62.6K 0.01% 1176
2015
Q2
$8.57M Buy
207,331
+15,800
+8% +$666K 0.01% 1108
2015
Q1
$8.6M Buy
191,531
+2,458
+1% +$103K 0.01% 1034
2014
Q4
$7.08M Sell
189,073
-1,815
-1% -$66.5K 0.01% 1156
2014
Q3
$6.67M Buy
190,888
+1,068
+0.6% +$38.1K 0.01% 1156
2014
Q2
$6.7M Buy
189,820
+19,965
+12% +$667K 0.01% 1216
2014
Q1
$5.54M Buy
169,855
+1,452
+0.9% +$55.5K 0.01% 1287
2013
Q4
$7.09M Sell
168,403
-2,337
-1% -$96.2K 0.01% 1117
2013
Q3
$6.81M Buy
170,740
+8,757
+5% +$367K 0.01% 1097
2013
Q2
$6.7M Buy
+161,983
New +$6.56M 0.01% 1019

Other funds holding HAE

BlackRock Investment Management's HAE Position: Q4 2016 in Review

BlackRock Investment Management increased its Haemonetics (HAE) stake by 19% in Q4 2016, buying an estimated $1.68M and bringing the position to 279,106 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #1046.

BlackRock Investment Management first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. 197 funds tracked by Wall St. Rank hold HAE as of Q4 2016.

  • BlackRock Investment Management held 279,106 shares of Haemonetics worth $11.2M as of Q4 2016.
  • BlackRock Investment Management bought 44,544 Haemonetics shares in Q4 2016, an estimated $1.68M.
  • Haemonetics made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1046 holding.
  • BlackRock Investment Management first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
  • 197 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.